phenyl acetate has been researched along with meglumine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzer, J; Lissner, J; McMahon, C; Pegios, W; Pirovano, G; Vogl, TJ; Waitzinger, J | 1 |
| Balzer, J; Lissner, J; Pegios, W; Pirovano, G; Vogl, TJ; Waitzinger, J | 1 |
| Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Cavagna, F; Daprà, M; de Haën, C; Felder, E; Maggioni, F | 1 |
| Elizondo, G; Fretz, CJ; Stark, DD | 1 |
| Felder, E; Musu, C; Tirone, P; Vittadini, G | 1 |
| Buoni, C; Felder, E; Musu, C; Passariello, R; Patrizio, G; Pavone, P; Tettamanti, E; Tirone, P | 1 |
| Cardone, G; Felder, E; Musu, C; Passariello, R; Patrizio, G; Pavone, P; Pietroletti, R; Tettamanti, E | 1 |
| Felder, E; Lorusso, V; Tirone, P; Vittadini, G | 1 |
| Goldhaber, JI; Kondo, RP; Weiss, JN | 1 |
| KIHLSTROM, JE | 1 |
| Fujita, M; Iwata, M; Ueda, T | 1 |
1 review(s) available for phenyl acetate and meglumine
| Article | Year |
|---|---|
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
1 trial(s) available for phenyl acetate and meglumine
| Article | Year |
|---|---|
[NMR tomography of the liver with the new contrast agent Gd-BOPTA. The results of an in-vivo phase-I test].
Topics: Acetates; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation; Gadolinium; Gallbladder; Humans; Kidney; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Spleen; Time Factors | 1992 |
11 other study(ies) available for phenyl acetate and meglumine
| Article | Year |
|---|---|
Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.
Topics: Acetates; Adult; Contrast Media; Drug Evaluation; Gallbladder; Humans; Kidney; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Spleen | 1992 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Gd-BOPTA/Dimeg: experimental disease imaging.
Topics: Acetates; Animals; Contrast Media; Coronary Disease; Gadolinium; Gadolinium DTPA; Liver Neoplasms, Experimental; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Liver-specific contrast agents for MRI.
Topics: Acetates; Animals; Contrast Media; Dextrans; Edetic Acid; Ethylenediamines; Ferrosoferric Oxide; Ferrous Compounds; Iron; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Rats | 1990 |
Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent.
Topics: Acetates; Animals; Contrast Media; Guinea Pigs; Hemodynamics; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Protein Binding; Rats | 1990 |
Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1990 |
[A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Topics: Acetates; Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gadolinium; Gadolinium DTPA; Lethal Dose 50; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds; Pentetic Acid; Rats | 1990 |
B-19036, a potential new hepatobiliary contrast agent for MR proton imaging.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Meglumine; Mice; Organometallic Compounds; Pentetic Acid; Rats; Tissue Distribution | 1988 |
Putative ryanodine receptors in the sarcolemma of ventricular myocytes.
Topics: Acetates; Animals; Caffeine; Calcium; Cells, Cultured; Chelating Agents; Cytoplasm; Ethylenediamines; Heart Ventricles; Ion Channels; Meglumine; Membrane Potentials; Myocardium; Patch-Clamp Techniques; Rabbits; Ruthenium Red; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcolemma; Sodium; Substrate Specificity | 2000 |
Osmotic pressures of water-solutions of methylglucamine-umbradil (3, 5-diiodine-4-pyridon-N-acetic acid) mixtures.
Topics: Acetates; Acetic Acid; Contrast Media; Meglumine; Osmotic Pressure | 1952 |
Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.
Topics: Acetates; Amines; Chemistry, Pharmaceutical; Drug Stability; Drug Storage; Excipients; Formaldehyde; Hypoglycemic Agents; Indoles; Magnetic Resonance Spectroscopy; Meglumine; Tablets; Technology, Pharmaceutical; Temperature; Time Factors | 2010 |